ASO Visual Abstract: Benefits of Surgical Treatment in Stage IV Breast Cancer in Patients with Known Hormone Receptor and HER2 Status
Kelly A. Stahl(University of Pittsburgh), Chan Shen(Pennsylvania State University), William G. Wong(Pennsylvania State University), Elizabeth J. Olecki(Pennsylvania State University), Ashton J. Brooks(Pennsylvania State University), Joseph A. Lewcun(Pennsylvania State University), Christopher J. McLaughlin(Pennsylvania State University), Daleela Dodge(Pennsylvania State University), Monali Vasekar(Pennsylvania State University), Kristina Newport(Pennsylvania State University)
Cited by 0
Related Papers
Comparison of Pediatric and Adult Hospice Patients Using Electronic Medical Record Data from Nine Hospices in the United States, 2008–2012
|Journal of Palliative Medicine|2014|37
Benefits of Surgical Treatment of Stage IV Breast Cancer for Patients With Known Hormone Receptor and HER2 Status
|Annals of Surgical Oncology|2020|32
Models of Outpatient Palliative Care Clinics for Patients With Cancer
|Journal of Oncology Practice|2019|24
Survival after palliative radiation therapy for cancer: The METSSS model
|Radiotherapy and Oncology|2021|23
Illness Understanding of Oncology Patients in a Community-Based Cancer Institute
|Journal of Oncology Practice|2017|20